{{Rsnum
|rsid=6413419
|Gene=CYP2E1
|Chromosome=10
|position=135345675
|Orientation=plus
|ReferenceAllele=G
|MissenseAllele=A
|GMAF=0.06657
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 4.4 | 95.6
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 7.5 | 44.2 | 48.3
| ASW | 3.5 | 38.6 | 57.9
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 2.0 | 98.0
| LWK | 0.9 | 28.7 | 70.4
| MEX | 0.0 | 8.6 | 91.4
| MKK | 0.0 | 16.0 | 84.0
| TSI | 0.0 | 7.8 | 92.2
| HapMapRevision=28
}}[[rs6413419]], also known as 4768G>A or V179I, is a SNP in the [[CYP2E1]] gene.

The [[rs6413419]](A) allele defines the CYP2E1*4 variant.

{{PMID Auto
|PMID=22126492
|Title=Genetic Polymorphisms of the CYP2E1 Gene do not Contribute to Oral Cancer Susceptibility in South Indians
}}

{{PMID Auto
|PMID=18663376
|Title=Global patterns of variation in allele and haplotype frequencies and linkage disequilibrium across the CYP2E1 gene.
|OA=1
}}

{{PMID Auto
|PMID=19131562
|Title=Biomarkers of human exposure to acrylamide and relation to polymorphisms in metabolizing genes.
|OA=1
}}

{{GET Evidence
|gene=CYP2E1
|aa_change=Val179Ile
|aa_change_short=V179I
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs6413419
|overall_frequency_n=943
|overall_frequency_d=10758
|overall_frequency=0.0876557
|n_genomes=14
|n_genomes_annotated=0
|n_haplomes=16
|n_articles=0
|n_articles_annotated=0
|pph2_score=0.23
|nblosum100=-4
|autoscore=0
|webscore=N
}}

{{PMID Auto
|PMID=22560290
|Title=A comparison of Val81Met and other polymorphisms of alcohol metabolising genes in patients and controls in Northern Spain.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}